Medication packaging – the principal differences between the EU and the USA to be aware of
Packaging has to satisfy a number of aims, such as: conserve the goods, avoid theft, be cheap, and maintain an equilibrium among its performance and its cost, both from the viewpoint of the material selected and the time occupied to form the packing.
From an eco-friendly perspective, it is of great importancy that materials are effortlessly recycled and used as small as possible.
Exist many products in the retail that can be mistaken between each other because of identical forms, colors or labels. Drug packaging should vary noticeably from hygiene and food products. For instance, US tablet packaging confounds a drug with a snack, and that is not the best idea… for the user. Packaging for human drugs is one of the major fields of design and research. And it would be good to take into consideration that, in this matter, there are obvious differences between the EU and the United States. While health in the US is a topic of privates and insurance economic matters, in most states in the EU it is governmental. This diversity changes the manner in which medications are seen by the public. Thus, American pharmacies sell a wide range of medications with a graphic pattern that in the EU is usual of more or less alimentary supplements.
On the other hand, in Europe, where the publicizing of medications is much more severe, the tablet packaging tends to fave a more practical look, with no applause and no recommendations. The reason for this difference in marketing communications is simple: the package’s target in Europe are doctors, while in the most of the US, the target of the package is the patient.